What is the market capitalization of Immix Biopharma, Inc.?

Immix Biopharma, Inc. (IMMX) has a market capitalization of approximately 600,843,186 USD.

How many ETFs hold IMMX?

IMMX is held by 1 ETFs tracked on Investir en Bourse.

Where can I buy IMMX in Canada?

IMMX can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

IMMX

Immix Biopharma, Inc.

Immix Biopharma, Inc. (IMMX) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 601 million USD (small-cap).

Details

Price8.44 USD

Market cap600.84 M USD

Payout ratio0.00%

ROE-74.46%

Debt / Equity1.23%

SectorHealthcare

Websiteimmixbio.com

Updated a few minutes ago

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.